Lyfe Capital, Sequoia Join $23M Series A+ Round In Burning Rock Biotech
August 17, 2015 — 16:59 CST
This Data Is Locked!
This area is available only to Subscribers.
Guangzhou-based cancer diagnostic start-up Burning Rock Biotech has completed RMB150 million (US$23 million) series A+ round of funding from Lyfe Capital, Sequoia Capital and Legend... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
